HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Tseng Selected Research

nicotinic receptor alpha4beta2

5/2010Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Tseng Research Topics

Disease

1Lung Neoplasms (Lung Cancer)
12/2023
1Acute Kidney Injury (Acute Renal Failure)
04/2016
1Hypokalemia
04/2016
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2015
1Tobacco Use Disorder (Nicotine Dependence)
05/2010

Drug/Important Bio-Agent (IBA)

1N-acetylVal-Nle(7,8)- allatotropin (5-13) (ATAA)IBA
12/2023
1DiureticsIBA
04/2016
1Azacitidine (5 Azacytidine)FDA Link
08/2015
1cytisineIBA
05/2010
1dianiclineIBA
05/2010
1Varenicline (Chantix)FDA Link
05/2010
1nicotinic receptor alpha4beta2IBA
05/2010